Original Research

Published on 15 Feb 2024

Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage

in Inflammation Pharmacology

Bhaskar Birru
Joachim G. S. Veit
Elizabeth M. Arrigali
Jack Van Tine
Emma Barrett-Catton
Zachary Tonnerre
Philippe Diaz
Monica A. Serban

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355283

1,772 views

Review

Published on 15 Feb 2024

Regulation of inflammation during wound healing: the function of mesenchymal stem cells and strategies for therapeutic enhancement

in Inflammation Pharmacology

Mingnan Gao
Han Guo
Xuan Dong
Zimao Wang
Zheng Yang
Qiaoli Shang
Qiying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345779

3,642 views
7 citations

Original Research

Published on 13 Feb 2024

Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats

in Inflammation Pharmacology

Linfu Yang
Xiying He
Dandan Zhi
Yunfei Xue
Xueyang Gong
Kun Dong
Yakai Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338432

1,588 views
2 citations

Systematic Review

Published on 07 Feb 2024

Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

in Inflammation Pharmacology

Huixia Liu
Yue Chen
Huan Wang
Xinyi Luo
Dengpiao Xie
Qing Ji
Li Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1350063

3,213 views
1 citation

Perspective

Published on 07 Feb 2024

Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator

in Inflammation Pharmacology

Jade Gauvin
David N. Huynh
Isabelle Dubuc
Catherine Lê
Rafaela Tugores
Nicolas Flamand
Louis Flamand
William D. Lubell
Huy Ong
Sylvie Marleau

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1303342

1,279 views

Review

Published on 02 Feb 2024

Therapeutic potential of hydrogen sulfide in osteoarthritis development

in Inflammation Pharmacology

Yunjia Song
Siyu Wu
Rong Zhang
Qing Zhong
Xuanming Zhang
Xutao Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1336693

3,583 views
3 citations

Original Research

Published on 23 Jan 2024

Mechanistic evaluation of antiarthritic and anti-inflammatory effect of campesterol ester derivatives in complete Freund’s adjuvant-induced arthritic rats

in Inflammation Pharmacology

Sarwat Nazir
Ishtiaq Ahmad
Aisha Mobashar
Ali Sharif
Arham Shabbir
Waqas Ashraf Chaudhary

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1346054

2,223 views
3 citations

Systematic Review

Published on 19 Jan 2024

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis

in Inflammation Pharmacology

Liang Dong
Lianghai Jiang
Zhengwei Xu
Xiaobo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1336075

3,257 views
1 citation

Original Research

Published on 15 Jan 2024

Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways

in Inflammation Pharmacology

Mi Zhou
Ling Meng
Qinke He
Chunguang Ren
Changyi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1321095

3,412 views
1 citation

Correction

Published on 11 Jan 2024

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

in Inflammation Pharmacology

Can G. Leineweber
Miriam Rabehl
Anne Pietzner
Nadine Rohwer
Michael Rothe
Maciej Pech
Bruno Sangro
Rohini Sharma
Chris Verslype
Bristi Basu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1354581

844 views

Original Research

Published on 09 Jan 2024

Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system

in Inflammation Pharmacology

Chunyan Wei
Wanhong Yin
Tingting Hu
Jingyi Zhang
Huifang Dan
Bin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1323240

2,120 views

Review

Published on 08 Jan 2024

Pterostilbene in the treatment of inflammatory and oncological diseases

in Inflammation Pharmacology

Peijun Liu
Weihua Tang
Kali Xiang
Guangcai Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1323377

5,711 views
3 citations

Mini Review

Published on 03 Jan 2024

Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy

in Inflammation Pharmacology

Xiao-Huan Wei
Yuan-Yuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326281

4,032 views
1 citation

Editorial

Published on 14 Dec 2023

Editorial: Implication of oxidative, inflammatory, apoptotic and autophagy pathways in colitis

in Inflammation Pharmacology

Hanan M. Hassan
Mohamed M. Salama

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326176

968 views

Systematic Review

Published on 07 Dec 2023

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

in Inflammation Pharmacology

Liuting Zeng
Qi He
Ying Deng
Yuwei Li
Junpeng Chen
Kailin Yang
Yanfang Luo
Anqi Ge
Xiaofei Zhu
Zhiyong Long

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189142

3,437 views
3 citations

Original Research

Published on 07 Dec 2023

A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system

in Inflammation Pharmacology

Huqun Li
Chongshu Wang
Aiping Deng
Cuilian Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1280490

2,515 views
1 citation

Navigation group

Articles

Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage

Regulation of inflammation during wound healing: the function of mesenchymal stem cells and strategies for therapeutic enhancement

Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats

Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator

Therapeutic potential of hydrogen sulfide in osteoarthritis development

Mechanistic evaluation of antiarthritic and anti-inflammatory effect of campesterol ester derivatives in complete Freund’s adjuvant-induced arthritic rats

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis

Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system

Pterostilbene in the treatment of inflammatory and oncological diseases

Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy

Editorial: Implication of oxidative, inflammatory, apoptotic and autophagy pathways in colitis

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system